Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 5.3B | 5.4B | 5.3B | 5.4B |
| Cost of revenue | 2.1B | 2.3B | 2.1B | 2.1B |
| Gross profit | 3.1B | 3.1B | 3.1B | 3.2B |
| Operating expense | ||||
| Research & development | 551M | 527M | 524M | 647M |
| Selling general and admin | 1.5B | 1.0B | 1.4B | 1.5B |
| Other operating expenses | 163M | -373M | 153M | 416M |
| Operating income | 1.0B | 1.2B | 1.1B | 793M |
| Non operating interest income | ||||
| Income | 28M | 24M | 35M | 65M |
| Expense | 78M | 59M | 89M | 72M |
| Other income expense | — | — | — | — |
| Pretax income | 956M | 809M | 1.0B | 785M |
| Tax provision | 218M | 140M | 231M | 180M |
| Net income | 738M | 669M | 812M | 605M |
| Basic EPS | 1.7 | — | 1.9 | 1.4 |
| Diluted EPS | 1.7 | — | 1.9 | 1.4 |
| Basic average shares | 434.9M | — | 434.9M | 434.8M |
| Diluted average shares | 434.9M | — | 434.9M | 434.8M |
| EBITDA | 1.5B | 1.8B | 1.6B | 1.5B |
| Net income from continuing op. | 738M | 669M | 812M | 605M |
| Minority interests | -3M | -3M | -3M | 2M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |